TickerFacts.

China SXT Pharmaceuticals, Inc. (SXTC): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.0K
Year ended 2025-03-31
-56.6%
5-year compound annual growth
$535.8K2017-03-31: $179.2K2018-03-31: $436.0K2019-03-31: $535.8K2020-03-31: $130.8K2024-03-31: $7.1K2025-03-31: $2.0K$2.0K
2017-03-31 Capital Expenditures (USD) 2025-03-31
Period endedCapital ExpendituresChange YoYSource filing
2025-03-31$2.0K-71.4%2026-07-01, From 2024-04-01
2024-03-31$7.1Kn/a2026-07-01, From 2023-04-01
No annual figure between 2020-03-31 and 2024-03-31.
2020-03-31$130.8K-75.6%2020-07-31, From 2019-04-01
2019-03-31$535.8K+22.9%2020-07-31, From 2018-04-01
2018-03-31$436.0K+143.3%2020-07-31, From 2017-04-01
2017-03-31$179.2Kn/a2019-08-15, From 2016-04-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31$2.0K-71.4%
Bespoke Extracts, Inc. (BSPK)2024-12-31$600.0Kn/a
Longeveron Inc. (LGVN)2025-12-31$245.0K-62.6%
Dare Bioscience, Inc. (DARE)2025-12-31$385.3K-32.8%
Vistagen Therapeutics, Inc. (VTGN)2024-03-31$0-100.0%
IGC Pharma, Inc. (IGC)2025-03-31$112.0K-18.8%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$139.9K+34.8%
Shattuck Labs, Inc. (STTK)2025-12-31$71.0K+20.3%
Cannapharmarx, Inc. (CPMD)2025-12-31$5.5Kn/a

Compare SXTC, BSPK, LGVN, DARE side by side · Screen every company in Pharmaceutical Preparations ↗